;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Pluristem Therapeutics financial update

    Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI), Haifa, Israel Business: Gene/Cell therapy Date announced: 2014-10-14 Note: Pluristem filed a shelf registration covering the sale of up to $200 million of its …

    Published on 10/20/2014
  • Selecta financial update

    Selecta Biosciences Inc., Watertown, Mass. Business: Drug delivery Date announced: 2014-10-15 Note: Selecta raised $20.5 million in an extension of a series D round, bringing the total raised in the round to $40 million…

    Published on 10/20/2014
  • Therapix financial update

    Therapix Biosciences Ltd. (Tel Aviv:TRPX; OTCQB:THXBY), Ness Ziona, Israel Business: Neurology, Autoimmune, Inflammation Date announced: 2014-10-07 Note: Therapix began trading its ADRs on the OTCQB under the ticker "…

    Published on 10/20/2014
  • DiaGenic proposes rights offering

    DiaGenic ASA (OSE:DIAG), Oslo, Norway Business: Diagnostic Date announced: 2014-09-08 Type: Rights offering To be raised: NOK35 million ($5.4 million) Shares: 53.8 million Price: NOK0.65 Shares outstanding prior: 285.1 …

    Published on 10/20/2014
  • Epigenomics proposes private placement

    Epigenomics AG (Xetra:ECX), Berlin, Germany Business: Genomics, Diagnostic Date announced: 2014-10-16 Type: Private placement To be raised: EUR4.2 million ($5.3 million) Shares: 1.4 million Price: EUR3.08 Shares …

    Published on 10/20/2014
  • International Stem Cell proposes private placement of convertible preferred stock and warrants

    International Stem Cell Corp. (OTCQB:ISCO), Carlsbad, Calif. Business: Gene/Cell therapy, Transplant Date announced: 2014-10-08 Type: Private placement of convertible preferred stock and warrants To be raised: $2.5 …

    Published on 10/20/2014
  • Neothetics proposes IPO

    Neothetics Inc., San Diego, Calif. Business: Ophthalmic, Endocrine/Metabolic Date announced: 2014-10-17 Type: IPO To be raised: Up to $63.3 million Shares: TBD Price: TBD Underwriters: Piper Jaffray; Guggenheim …

    Published on 10/20/2014
  • PolyPid proposes IPO

    PolyPid Ltd., Petach Tikva, Israel Business: Drug delivery Date announced: 2014-10-14 Type: IPO To be raised: Up to $23 million Shares: TBD Price: TBD Underwriters: Aegis Capital; MLV; Chardan Capital Markets Note: The …

    Published on 10/20/2014
  • Dance Biopharm withdraws IPO

    Dance Biopharm Inc., Brisbane, Calif. Business: Endocrine/Metabolic Date announced: 2014-10-15 Type: IPO Underwriters: Wells Fargo; Stifel, Nicolaus & Co.; Oppenheimer; Roth Capital Partners Note: The company withdrew …

    Published on 10/20/2014
  • Probiodrug amends IPO

    Probiodrug AG, Halle/Saale, Germany Business: Neurology, Autoimmune, Inflammation Date announced: 2014-10-10 Type: IPO To be raised: Up to EUR28 million ($35.1 million) Shares: 1.5 million Price: EUR15.25-EUR19 …

    Published on 10/13/2014
  • Proteon amends IPO

    Proteon Therapeutics Inc., Waltham, Mass. Business: Cardiovascular Date announced: 2014-10-07 Type: IPO To be raised: Up to $65.8 million Shares: 4.7 million Price: $12-$14 Underwriters: Stifel, Nicolaus; JMP Securities…

    Published on 10/13/2014
  • Virobay amends IPO

    Virobay Inc., Menlo Park, Calif. Business: Autoimmune, Neurology, Hepatic Date announced: 2014-10-06 Type: IPO To be raised: Up to $53.8 million Shares: 3.8 million Price: $12-$14 Underwriters: Piper Jaffray; JMP …

    Published on 10/13/2014
  • Xenon amends IPO

    Xenon Pharmaceuticals Inc., Burnaby, B.C. Business: Pharmacogenetics, Neurology, Endocrine/Metabolic Date announced: 2014-10-09 Type: IPO To be raised: Up to $48 million Shares: 4 million Price: $10-$12 Underwriters: …

    Published on 10/13/2014
  • Anacor completes private placement of senior convertible notes

    Anacor Pharmaceuticals Inc. (NASDAQ:ANAC), Palo Alto, Calif. Business: Infectious, Dermatology, Autoimmune Date completed: 2014-10-09 Type: Private placement of senior convertible notes Raised: $75 million Shares …

    Published on 10/13/2014
  • Anacor completes private placement of senior convertible notes

    Anacor Pharmaceuticals Inc. (NASDAQ:ANAC), Palo Alto, Calif. Business: Infectious, Dermatology, Autoimmune Date completed: 2014-10-09 Type: Private placement of senior convertible notes Raised: $8 million Shares …

    Published on 10/13/2014
  • Assembly Biosciences completes direct public offering

    Assembly Biosciences Inc. (NASDAQ:ASMB), New York, N.Y. Business: Gastrointestinal, Genitourinary, Infectious Date completed: 2014-10-01 Type: Direct public offering Raised: $15.8 million Shares: 2 million Price: $8.04 …

    Published on 10/13/2014
  • Avidity completes venture financing

    Avidity NanoMedicines LLC, La Jolla, Calif. Business: Cancer Date completed: 2014-10-07 Type: Venture financing Raised: $6 million Investors: Fidelity Biosciences; TPG Biotech; Brace Pharmaceuticals Inc.; Partner Fund …

    Published on 10/13/2014
  • Biogazelle completes venture financing

    Biogazelle N.V., Zwijnaarde, Belgium Business: Supply/Service Date completed: 2014-10-06 Type: Venture financing Raised: EUR2 million ($2.5 million) Investors: Qbic Arkiv Fund; PMV N.V.; Foundation Fournier-Majoie

    Published on 10/13/2014
  • BioTime completes direct public offering

    BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 2014-10-09 Type: Direct public offering Raised: $29.4 million Shares: 9.4 million Price: $3.12 Shares after …

    Published on 10/13/2014
  • Great Basin completes IPO

    Great Basin Corp. (NASDAQ:GBSN), Salt Lake City, Utah Business: Diagnostic Date completed: 2014-10-09 Type: IPO Raised: $8.1 million Shares: 1.2 million Price: $7 (unit) Shares after offering: 5.1 million Underwriters: …

    Published on 10/13/2014
  • Ignyta completes debt financing

    Ignyta Inc. (NASDAQ:RXDX), San Diego, Calif. Business: Cancer, Diagnostic Date completed: 2014-10-01 Type: Debt financing Raised: $21 million Investor: Silicon Valley Bank Note: The company drew down $21 million of a …

    Published on 10/13/2014
  • Kesios completes venture financing

    Kesios Therapeutics Ltd., London, U.K. Business: Cancer Date completed: 2014-10-08 Type: Venture financing Raised: L1.9 million ($3 million) Investor: Imperial Innovations Group plc

    Published on 10/13/2014
  • Levicept completes venture financing

    Levicept Ltd., Sandwich, U.K. Business: Neurology, Autoimmune Date completed: 2014-10-07 Type: Venture financing Raised: L10 million ($16 million) Investors: Advent Life Sciences; Gilde; Index Ventures

    Published on 10/13/2014
  • Magnus Life Science completes venture financing

    Magnus Life Science, London, U.K. Business: Cardiovascular, Endocrine/Metabolic, Cancer Date completed: 2014-10-07 Type: Venture financing Raised: L15.5 million ($24.8 million) Investor: Private investor

    Published on 10/13/2014
  • Mimetas completes venture financing

    Mimetas B.V., Leiden, the Netherlands Business: Microfluidics Date completed: 2014-10-08 Type: Venture financing Raised: $5.2 million Investors: PPM Oost; Zeeuws InvesteringsFonds

    Published on 10/13/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993